Edges in Network
Network | GSE5851_top500tf - GSE5851 - SiGN-BN HC+Bootstrap |
Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
Node | TFAP2A |
Upstream (Parents) |
---|
(<<) TRIM29 → TFAP2A |
(<<) BHLHE41 → TFAP2A |
(<<) AR → TFAP2A |
(<<) SPDEF → TFAP2A |
(<<) NR5A2 → TFAP2A |
(<<) MAFF → TFAP2A |
(<<) FOSL1 → TFAP2A |
(<<) ZNF93 → TFAP2A |
(<<) NR1I2 → TFAP2A |
(<<) CREB3L1 → TFAP2A |
(<<) ZNF165 → TFAP2A |
(<<) KLF4 → TFAP2A |
(<<) CEBPA → TFAP2A |
(<<) SOX13 → TFAP2A |
(<<) LMO4 → TFAP2A |
(<<) ARNTL2 → TFAP2A |
Downstream (Children) |
---|
TFAP2A → NEUROD1 (>>) |
TFAP2A → ISL1 (>>) |
TFAP2A → NKX3-2 (>>) |
TFAP2A → PAX6 (>>) |
TFAP2A → HMG20B (>>) |
TFAP2A → MYF5 (>>) |
TFAP2A → BLZF1 (>>) |
TFAP2A → PDX1 (>>) |
TFAP2A → RXRB (>>) |
TFAP2A → SOX15 (>>) |
TFAP2A → PPBPL2 (>>) |